Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
Fortrea Holdings Inc. (FTRE)
Company Research
Source: GlobeNewswire
DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity and inclusion (D&I) of participants in clinical trials. Fortrea’s D&I solution is designed to expand patient access to participate in clinical trials and address the U.S. Food and Drug Administration (FDA) requirements, under The Food and Drug Omnibus Reform Act, to increase enrollment of underrepresented populations in clinical trials. Fortrea’s comprehensive process integrates five components of diversity action planning and execution: Real-world evidence advisors research relevant real-world data sets to inform diversity planning.Regulatory, development and clinical operational experts design the Diversity Action Plan, validate with patient groups and negotiate with regulators.Operational teams access multiple data platforms, Fortrea’s Site Advisory Board a
Show less
Read more
Impact Snapshot
Event Time:
FTRE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FTRE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FTRE alerts
High impacting Fortrea Holdings Inc. news events
Weekly update
A roundup of the hottest topics
FTRE
News
- Fortrea to Participate in Virtual Fireside Chat with Evercore ISIGlobeNewswire
- Fortrea Holdings Inc. (NASDAQ: FTRE) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $28.00 price target on the stock.MarketBeat
- Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital PartnersGlobeNewswire
- Fortrea to Present at the Jefferies Global Healthcare ConferenceGlobeNewswire
- Fortrea Holdings Inc. (NASDAQ: FTRE) is now covered by analysts at TD Cowen. They set a "hold" rating and a $27.00 price target on the stock.MarketBeat
FTRE
Earnings
- 5/13/24 - Miss
FTRE
Sec Filings
- 6/20/24 - Form 8-K
- 6/7/24 - Form 8-K/A
- 6/4/24 - Form 8-K
- FTRE's page on the SEC website